Characteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate with Different BCR-ABL Transcripts Levels Response. MLU [Internet]. 2021 Jan. 9 [cited 2026 Jun. 15];21(1):949-55. Available from: https://ijop.net/index.php/mlu/article/view/2438